Related Experiment Video

Updated: Jul 10, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

KL-6 and poor prognosis in NSCLC patients treated with gefitinib

Gen Ohara, Koichi Kurishima, Hiroichi Ishikawa

    Lung Cancer (Amsterdam, Netherlands)
    |November 17, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Concept Videos